HIF1A and neoplasm: BRD4 inhibition was also shown to decrease M2 tumor-associated macrophage (TAM) proliferation, particularly by directly inhibiting HIF1α expression in tumor cells, thereby inhibiting the secretion of M2-promoting colony-stimulating factor 1 (CSF1) [179].